Gerard (Art) V.
- Country
- The Netherlands
- Department
- Internal Medicine
Research Overview
Data & Insights
Has run more than one trial at 0 of 13 partner sites.
Specializations
Melanoma Treatment Innovation
This investigator specializes in advancing treatment approaches for stage III melanoma and metastatic melanoma, with particular focus on immunotherapy combinations and treatment optimization strategies.
- Neoadjuvant Immunotherapy
- Adjuvant Treatment Protocols
- Treatment Response Assessment
The investigator's work encompasses evaluation of targeted therapies and immunotherapy agents including ipilimumab and nivolumab combinations.
Treatment Optimization
A key focus area involves investigating optimal treatment duration and discontinuation strategies for patients receiving immunotherapy combinations for advanced melanoma.
- Response Monitoring
- Treatment Duration Assessment
- Patient Outcome Evaluation
The research extends to evaluating early discontinuation protocols in patients achieving clinical responses.
Clinical Response Evaluation
The investigator specializes in assessing therapeutic outcomes in advanced skin cancer treatment, with emphasis on event-free survival and response durability.
- Response Criteria Development
- Survival Analysis
- Treatment Efficacy Assessment
Research activities include evaluation of pathologic response patterns and long-term treatment outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.